Paraneoplastic pemphigus in association with hepatocellular carcinoma

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 538-540

  Hinterhuber, Gabriele ^a,b   Drach, Johannes ^a   Riedl, Elisabeth ^a   Böhler, Kornelia ^a   Ferenci, Peter ^a   Wolff, Klaus ^a   Foedinger, Dagmar ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIFUNGAL AGENT; AZATHIOPRINE; FLUCONAZOLE; PREDNISOLONE; STEROID;

AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DISEASE ASSOCIATION; DYSPHAGIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PERITONEUM METASTASIS; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0041324806     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)01581-0     Document Type: Article

References (14)

1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-35.
2. Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin. J Invest Dermatol 2001;116:556-63.
3. Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto I. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998;102:775-82.
4. Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pemphigus variants. J Am Acad Dermatol 1999;40:649-71.
5. Matz H, Milner Y, Frusic-Zlotkin M, Brenner S. Paraneoplastic pemphigus associated with pancreatic carcinoma. Acta Derm Venereol 1997;77:289-91.
6. Lam S, Stone MS, Goeken JA, Massicotte SJ, Smith AC, Folberg P, et al. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with patchydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmology 1992;99:108-13.
7. Foedinger D, Anhalt GJ, Boecskoer B, Elbe A, Wolff K, Rappersberger K. Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 1995;181:169-79.
8. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997;12:77-96.
9. Oka D, Shimoda A, Ueki H, Ohmoto K, Yamamoto S. Coexistence of pemphigus vulgaris, myasthenia gravis and hepatocellular carcinoma. Dermatologica 1986;172:177-8.
10. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998;110:103-9.
11. Nousari HC, Kimyai-Asadi A, Anhalt GJ. Elevated serum levels of interleukin-6 in paraneoplastic pemphigus. J Invest Dermatol 1999;112:396-8.
12. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
13. Kirsner RS, Anhalt GJ, Kerdel FA. Treatment of alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995;132:474-8.
14. Giannitrapani L, Cervello M, Soresi M, Notarbartolo M, La Rosa IV, Virruso L, et al. Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann N Y Acad Sci 2002;963:46-52.